In this study, FOXA2-interacting FOXP2 was confirmed to act as an EMT suppressor during metastasis in breast cancer cells, adding a new Fox transcription factor to the list of EMT regulators and also providing a further support of FOXA2’s roles on EMT inhibition. This evidence concerns the gene FOXP2 and breast carcinoma.